In the original article, there was a mistake in [Tables 1](#T1){ref-type="table"}--[4](#T4){ref-type="table"} as published. The units for Procalcitonin (PCT) concentration were erroneously stated as ng/mL, but should be stated as pg/mL. The corrected Tables appear below.

###### 

Comparisons of blood biomarker concentration with effusion biomarker concentrations in dogs with septic peritonitis (SP) and in dogs with non-septic peritonitis (NSA).

                        **SP**          **NSA**                                                                      
  --------------------- --------------- ---------------- -------- ------------ -------------- ------------- -------- ------------
  Glucose (mg/dL)       111             20               0.0011   **0.0121**   101            94            0.1648   1.8128
                        81--124         20--108                                79--118        78--99                 
  Glucose (mmol/L)      6.2             1.1              0.0011   **0.0121**   5.6            5.2           0.1648   1.8128
                        4.5--6.9        1.1--6.0                               4.4--6.6       4.4--5.5      0.1648   1.8128
  Lactate (mmol/L)      2.7             7.9              0.0066   0.0726       2.0            1.8           0.6998   7.6978
                        1.2--4.2        2.7--11.3                              1.3--2.6       1.1--2.8               
  cfDNA (ng/mL)         379             1085             0.0003   **0.0033**   410            470           0.7381   8.1191
                        316--430        493--2723                              316--629       269--1157              
  Nucleosomes (AU)      0.35            13.1             0.0001   **0.0011**   0.6            2.5           0.0289   0.1848
                        0.2--1.1        4.4--25.1                              0.3--1.8       0.3--12.9              
  NT--proCNP (pmol/L)   11.9            6.2              0.2460   2.910        3.9            2.3           0.1134   1.333
                        5.6--42.1       1.9--25.7                              2.3--12.0      1.6--10.3              
  PCT (pg/mL)           99.6            38.4             0.0028   **0.0352**   93.5           98.9          0.6226   6.8486
                        40.3--182.9     0.0--119.2                             54.7--208.1    29.7--201.6            
  CCL2 (pg/mL)          1274            16066            0.0001   **0.0011**   249            683           0.0001   **0.0011**
                        282--2715       2508--96300                            21--431        449--2225              
  CXCL8 (pg/mL)         785.4           4325.0           0.0090   0.099        550.3          129.6         0.1901   2.0911
                        495.6--1857.0   21.7--75000.0                          51.8--1372.0   21.7--444.7            
  IL-10 (pg/mL)         8.5             303.1            0.0012   **0.0132**   8.5            8.5           0.0312   0.3432
                        8.5--106.4      147.6--1584.0                          8.5--8.5       8.5--31.9              
  IL-6 (pg/mL)          9.9             2775.0           0.0001   **0.0011**   3.7            37.9          0.0029   **0.0319**
                        3.7--1573.0     363.5--11495.0                         3.7--15.9      3.7--1918.0            
  KC-Like (pg/mL)       164.1           1215.0           0.0011   **0.0121**   20.3           456.2         0.0001   **0.0011**
                        8.0--1137.0     37.2--6973.0                           5.3--71.5      62.1--757.0            

*Median and IQR concentrations of measured biomarkers in blood and effusion in patients with SP and NSA, and results of univariate comparisons of biomarker concentrations between fluid types with each group by Wilcoxon matched-pairs signed rank test. Biomarkers significantly different after correction for multiple comparisons (P \<0.05) between blood and effusion within SP and NSA groups are indicated in bold typeface. AU, arbitrary unit; CCL2, C-C Motif Chemokine Ligand-2; cfDNA, cell-free DNA; CXCL8, chemokine C-X-C motif ligand 8; IL, interleukin; IQR, interquartile range; KC-Like, keratinocyte chemoattractant-like; NSA, non-septic ascites; NT-proCNP, amino-terminal propeptide of C-type natriuretic peptide; P~corr~, P-value corrected for multiple comparisons; PCT, procalcitonin; SP, septic peritonitis*.

###### 

Comparisons of blood biomarker concentrations in dogs with septic peritonitis (SP) and non-septic peritonitis (NSA).

                       **Blood**                               
  -------------------- --------------- -------------- -------- ------------
  Glucose (mg/dL)      111             101            0.7927   8.7197
                       81--124         79--118                 
  Glucose (mmol/L)     6.2             5.6            0.7927   8.7197
                       4.5--6.9        4.4--6.6                
  Lactate (mmol/L)     2.7             2.0            0.3698   4.0678
                       1.2--4.2        1.3--2.6                
  cfDNA (ng/mL)        379             410            0.3953   4.3483
                       316--430        316--629                
  Nucleosomes (AU)     0.35            0.60           0.2043   2.2473
                       0.2--1.1        0.3--1.8                
  NT-proCNP (pmol/L)   11.9            3.9            0.0399   0.4389
                       5.6--42.1       2.3--12.0               
  PCT (pg/mL)          99.6            93.5           0.7299   8.0289
                       40.3--182.9     54.7--208.1             
  CCL2 (pg/mL)         1274            249            0.0029   **0.0319**
                       282--2715       21--431                 
  CXCL8 (pg/mL)        785.4           550.3          0.188    2.068
                       495.6--1857.0   51.8--1372.0            
  IL-10 (pg/mL)        8.5             8.5            0.008    0.088
                       8.5--106.4      8.5--8.5                
  IL-6 (pg/mL)         9.9             3.7            0.0680   0.748
                       3.7--1573.0     3.7--15.9               
  KC-Like (pg/mL)      164.1           20.3           0.0731   0.8041
                       8.0--1137.0     5.3--71.5               

*Median and IQR concentrations of measured biomarkers in blood in patients with SP and NSA, and results of univariate comparisons of biomarker concentrations between groups by Mann-Whitney U-test. Biomarkers identified to be significantly different in blood compared between SP and NSA groups after correction for multiple comparisons (P \<0.05) are indicated in bold typeface. AU, arbitrary unit; CCL2, C-C Motif Chemokine Ligand-2; cfDNA, cell-free DNA; CXCL8, chemokine C-X-C motif ligand 8; IL, interleukin; IQR, interquartile range; KC-Like, keratinocyte chemoattractant-like; NSA, non-septic ascites; NT-proCNP, amino-terminal propeptide of C-type natriuretic peptide; P~corr~, P value corrected for multiple comparisons; PCT, procalcitonin; SP, septic peritonitis*.

###### 

Comparisons of effusion biomarker concentrations in dogs with septic peritonitis (SP) and non-septic peritonitis (NSA).

                       **Effusion**                            
  -------------------- ---------------- ------------- -------- ------------
  Glucose (mg/dL)      20               94            0.011    0.121
                       20--108          78--99                 
  Glucose (mmol/L)     1.1              5.2           0.011    0.121
                       1.1--6.0         4.3--5.5               
  Lactate (mmol/L)     7.9              1.8           0.0001   **0.0011**
                       2.7--11.3        1.1--2.8               
  cfDNA (ng/mL)        1085             470           0.0205   0.2255
                       493--2723        269--1157              
  Nucleosomes (AU)     13.1             2.5           0.0056   0.0616
                       4.4--25.1        0.3--12.9              
  NT-proCNP (pmol/L)   6.2              2.3           0.2806   3.0866
                       1.9--25.7        1.6--10.3              
  PCT (pg/mL)          38.4             98.9          0.0489   0.5379
                       0--119.2         29.7--201.6            
  CCL2 (pg/mL)         16066            683           0.0011   **0.0121**
                       2508--96300      449--2225              
  CXCL8 (pg/mL)        4325.0           129.6         0.0113   0.1243
                       21.7--75000.0    21.7--444.7            
  IL-10 (pg/mL)        303.1            8.5           0.0001   **0.0011**
                       147.6--1584.0    8.5--31.9              
  IL-6 (pg/mL)         2775.0           37.9          0.0011   **0.0121**
                       363.5--11495.0   3.7--1918.0            
  KC-Like (pg/mL)      1215.0           456.2         0.312    3.432
                       37.2--6973.0     62.1--757.0            

*Median and IQR concentrations of measured biomarkers in effusion in patients with SP and NSA, and results of univariate comparisons of biomarker concentrations between groups by Mann-Whitney U-test. Biomarkers identified to be significantly different in effusion compared between SP and NSA groups after correction for multiple comparisons (P \<0.05) are indicated in bold typeface. AU, arbitrary unit; CCL2, C-C Motif Chemokine Ligand-2; cfDNA, cell-free DNA; CXCL8, chemokine C-X-C motif ligand 8; IL, interleukin; IQR, interquartile range; KC-Like, keratinocyte chemoattractant-like; NSA, non-septic ascites; NT-proCNP, amino-terminal propeptide of C-type natriuretic peptide; P~corr~, P value corrected for multiple comparisons; PCT, procalcitonin; SP, septic peritonitis*.

###### 

Comparisons of blood-effusion biomarker concentration gradients in dogs with septic peritonitis (SP) and non-septic peritonitis (NSA).

                       **Blood-Effusion Gradient**                              
  -------------------- ----------------------------- ----------------- -------- ------------
  Glucose (mg/dL)      59                            6                 0.0009   **0.0099**
                       16--91                        −6--27                     
  Glucose (mmol/L)     3.3                           0.3               0.0009   **0.0099**
                       0.9--5.1                      −0.3--1.5                  
  Lactate (mmol/L)     −4.9                          0.2               0.0015   **0.0165**
                       −8.5 to −0.5                  −0.9--0.6                  
  cfDNA (ng/mL)        −757                          −31               0.005    0.055
                       −2331 to −179                 −527--165                  
  Nucleosomes (AU)     −13.0                         −0.7              0.0066   0.0726
                       −22.5 to −3.4                 −12.8--0.3                 
  NT-proCNP (pmol/L)   2.4                           0.8               0.3744   4.1624
                       −1.6--7.4                     −0.5--2.6                  
  PCT (pg/mL)          27.9                          22.4              0.0861   0.9471
                       8.3--98.7                     −32.7--33.7                
  CCL2 (pg/mL)         −14151                        −561              0.0006   **0.0066**
                       −91817 to −2243               −1827 to −110              
  CXCL8 (pg/mL)        −3657.0                       134.1             0.0129   0.1419
                       −68631.0--623.7               −51.1--1316.0              
  IL-10 (pg/mL)        −294.6                        0.0               0.0004   **0.0044**
                       −1430.0 to −63.8              −23.4 to 0.0               
  IL-6 (pg/mL)         −2772.0                       −0.5              0.0009   **0.0099**
                       −10272.0 to −359.8            −1914.0 to 0.0             
  KC-Like (pg/mL)      −937.3                        −425.5            0.3786   4.1646
                       −4615.0 to −31.9              −716.7 to −41.3            

*Median and IQR blood-effusion concentration gradients of measured biomarkers in patients with SP and NSA, and results of univariate comparisons of biomarker concentration gradients between groups by Mann-Whitney U-test. Biomarker bloodeffusion gradients identified to be significantly different compared between SP and NSA groups after correction for multiple comparisons (P \<0.05) are indicated in bold typeface. AU, arbitrary unit; CCL2, C-C Motif Chemokine Ligand-2; cfDNA, cell-free DNA; CXCL8, chemokine C-X-C motif ligand 8; IL, interleukin; IQR, interquartile range; KC-Like, keratinocyte chemoattractant-like; NSA, non-septic ascites; NT-proCNP, amino-terminal propeptide of C-type natriuretic peptide; P~corr~, P value corrected formultiple comparisons; PCT, procalcitonin; SP, septic peritonitis*.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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